Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells
- 1 August 2019
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1866 (8) , 1322-1337
Abstract
No abstract availableKeywords
Funding Information
- East Carolina University (111104-668715-0000, 111110-668715-0000)
This publication has 217 references indexed in Scilit:
- Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer CellsCancer Cell, 2012
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP PathwayCell, 2011
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and ActivityCancer Cell, 2011
- FoxOs Inhibit mTORC1 and Activate Akt by Inducing the Expression of Sestrin3 and RictorDevelopmental Cell, 2010
- Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancerOncogene, 2010
- From Promiscuity to Precision: Protein Phosphatases Get a MakeoverMolecular Cell, 2009
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolismNature, 2009
- Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signallingThe EMBO Journal, 2008
- S6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of AktMolecular Cell, 2006
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004